These strategies are effective at stopping leaksBy Ashley AbramsonBladder leaks can be disruptive—and they’re very common. Up ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation’s ...

Findings in patients with interstitial cystitis/bladder pain syndrome can help with diagnosis of interstitial cystitis subtypes ...

BLADDER cancer is classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC) ...

When it comes to specialized healthcare, finding the right medical professional is crucial. If you are looking for the best ...

Millions of adults have bladder problems. Some people have sudden, strong urges to urinate or an uncontrollable flow. Others ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Blue light cystoscopy had a statistically significant reduction in risk of recurrence versus white light cystoscopy in ...

Discover a study that found that the combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible ...

ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...

Bladder cancer is one of the most commonly diagnosed cancers, yet many patients face delays in diagnosis or struggle to find the right care. Are you navigating a bladder cancer diagnosis or unsure of ...

Updated clinical & translational results: BOND-003 Cohort C- A phase 3, single-arm study of intravesical cretostimogene grenadenorepvec for high-risk BCG-unresponsive non-muscle invasive bladder ...